|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/166 | |
| A61K 31/353 | |||
| A61K 31/404 | |||
| A61K 31/4184 | |||
| A61K 31/4412 | |||
| A61K 31/506 | |||
| A61K 31/517 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61P 17/00 |
| (11) | Number of the document | 2211849 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08837957.3 |
| Date of filing the European patent application | 2008-10-10 | |
| (97) | Date of publication of the European application | 2010-08-04 |
| (45) | Date of publication and mention of the grant of the patent | 2013-07-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2008/003415 |
| Date | 2008-10-10 |
| (87) | Number | WO 2009/047505 |
| Date | 2009-04-16 |
| (30) | Number | Date | Country code |
| 0719771 | 2007-10-10 | GB |
| (72) |
YOUNG, Malcolm, Philip, GB
THOMAS, Catherine, Mary, GB
IDOWU, Olusola, Clement, GB
CHARLTON, Julie Anne, GB
|
| (73) |
E-Therapeutics plc,
17 Blenheim Office Park, Long Hanborough Oxfordshire OX29 8LN,
GB
|
| (54) | Dexanabinol with inhibitors of BRAF or MEK for the treatment of melanoma. |
| Dexanabinol with inhibitors of BRAF or MEK for the treatment of melanoma. |